QTREX Quantum corrects CEO's reported holdings

Shareholders approved the RSU grant at an Extraordinary General Meeting held on August 28, 2026.

This filing corrects an earlier one, and you can read the original Form 4 if you want to see what changed.

Rhea-AI Filing Summary

QTREX Quantum Ltd.’s Chief Executive Officer and director, Dagi Shahar Ben-Noon, was granted 550,000 restricted share units (RSUs) on August 28, 2026, under the company’s 2019 Plan. The amendment corrected the reported amount of securities beneficially owned following the transaction to 3,477,239, from 2,477,239.

Insider Trade Summary

Grant/Award: 550,000 shares

Grant/Award 1 txn

Insider Ben-Noon Dagi Shahar

Role Chief Executive Officer

Type	Security	Shares	Price	Value
Grant/Award	Ordinary Shares F1, F2	550,000	$0.00	$0.00

Holdings After Transaction: Ordinary Shares — 3,477,239 shares (Direct)

Footnotes (2)

1. F1. The Restricted Share Units ("RSUs") were granted under Qtrex Quantum Ltd.'s (formerly Insense Medical) 2019 Plan, and will vest according to the following schedule: (i) 33.34% of the RSUs will vest on the first anniversary date following July 1, 2026 (the "First Instalment"); and (ii) 8.33% of the RSUs will vest on a quarterly basis over 8 quarters (two (2) years), following the First Instalment. The grant of RSUs was approved by the Company's shareholders at an Extraordinary General Meeting of Shareholders held on August 28, 2026.
2. F2. This Form 4 Amendment is being filed solely to correct the amount of securities beneficially owned following reported transaction from 2,477,239 to 3,477,239.

Key Figures

RSUs granted: 550,000 RSUs Reported beneficial ownership following the transaction: 3,477,239 securities Previously reported beneficial ownership following the transaction: 2,477,239 securities +2 more

5 metrics

RSUs granted 550,000 RSUs Granted August 28, 2026

Reported beneficial ownership following the transaction 3,477,239 securities Corrected amount

Previously reported beneficial ownership following the transaction 2,477,239 securities Amount corrected by the amendment

First vesting installment 33.34% of the RSUs On the first anniversary date following July 1, 2026

Quarterly vesting installments 8.33% of the RSUs per quarter Over eight quarters following the First Instalment

Key Terms

Restricted Share Units, vest, First Instalment

3 terms

Restricted Share Units financial

"The Restricted Share Units ("RSUs") were granted under"

Restricted share units (RSUs) are a promise from a company to give an employee or service provider actual shares or cash equal to the shares after certain conditions are met, typically staying with the company for a set time or hitting performance targets. Think of them like a time-locked gift card that becomes usable only after you’ve earned it. For investors, RSUs matter because they align employee incentives with company performance and can increase the number of shares outstanding over time, diluting existing ownership and affecting earnings per share.

vest financial

"will vest according to the following schedule"

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

First Instalment financial

"the "First Instalment""

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many RSUs were awarded to QTEX CEO Dagi Shahar Ben-Noon?

Dagi Shahar Ben-Noon was granted 550,000 RSUs on August 28, 2026. The amendment corrected the reported amount of securities beneficially owned following the transaction to 3,477,239, from 2,477,239.

What is the vesting schedule for the QTEX RSUs?

The RSUs vest 33.34% on the first anniversary date following July 1, 2026, then 8.33% quarterly over eight quarters (two years) following the First Instalment.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/29/2026 - 01:49 PM Accepted by SEC EDGAR 09/29/2026 - 01:49 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Ben-Noon Dagi Shahar

(Last) (First) (Middle)

2 ILAN RAMON ST.

(Street)

NESS-ZIONA 7492625

(City) (State) (Zip)

ISRAEL

(Country)

2. Issuer Name and Ticker or Trading Symbol
QTREX Quantum Ltd. [ QTEX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/28/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)
09/01/2026

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	08/28/2026		A		550,000(1)	A	$0	3,477,239(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The Restricted Share Units ("RSUs") were granted under Qtrex Quantum Ltd.'s (formerly Insense Medical) 2019 Plan, and will vest according to the following schedule: (i) 33.34% of the RSUs will vest on the first anniversary date following July 1, 2026 (the "First Instalment"); and (ii) 8.33% of the RSUs will vest on a quarterly basis over 8 quarters (two (2) years), following the First Instalment. The grant of RSUs was approved by the Company's shareholders at an Extraordinary General Meeting of Shareholders held on August 28, 2026.

2. This Form 4 Amendment is being filed solely to correct the amount of securities beneficially owned following reported transaction from 2,477,239 to 3,477,239.

	/s/ Dagi Ben-Noon	09/29/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)